APA (7th ed.) Citation

Farrash, W. F., Idris, S., Elzubier, M. E., Khidir, E. B. A., Aslam, A., Mujalli, A., . . . Refaat, B. (2024). Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction‐associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways. International Journal of Experimental Pathology, 105(6), 219. https://doi.org/10.1111/iep.12519

Chicago Style (17th ed.) Citation

Farrash, Wesam F., et al. "Enhanced Hepatoprotective Effects of Empagliflozin and Vitamin D Dual Therapy Against Metabolic Dysfunction‐associated Steatohepatitis in Mice by Boosted Modulation of Metabolic, Oxidative Stress, and Inflammatory Pathways." International Journal of Experimental Pathology 105, no. 6 (2024): 219. https://doi.org/10.1111/iep.12519.

MLA (9th ed.) Citation

Farrash, Wesam F., et al. "Enhanced Hepatoprotective Effects of Empagliflozin and Vitamin D Dual Therapy Against Metabolic Dysfunction‐associated Steatohepatitis in Mice by Boosted Modulation of Metabolic, Oxidative Stress, and Inflammatory Pathways." International Journal of Experimental Pathology, vol. 105, no. 6, 2024, p. 219, https://doi.org/10.1111/iep.12519.